SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.51+2.7%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Bong who wrote (3307)4/2/2001 4:46:30 PM
From: Jibacoa  Read Replies (1) of 52153
 
Mr.Bong with all due respect, CNBC is just talking about Lehman's Bros. outlook for Biotechs stating they see a possible another 20 to 30% further correction even for the large caps. They claim they see no reason for the Biotechs to be selling at a premium over Pharmas.

I am also a long-term investor ( I don't know how long you have been, but I started in 1958 ), however I still think that the primary concern of any "investor" wether short or long term should be as Warrent Buffett ounce stated "NOT TO LOOSE ANY MONEY"

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News